Effect of exercise and pharmacotherapy on non-alcoholic fatty liver disease.

ABSTRACT:

Objectives

Nonalcoholic fatty liver disease is one of the emerging liver diseases affecting 20%-30% of the population creating a burden on public health worldwide and has been associated with the causation of multiple diseases. Besides exercise, several drugs are being used in patients based on clinical evidence especially vitamin E, a potent antioxidant to reduce the oxidative stress responsible for the development and progression of nonalcoholic fatty liver disease. This study aims at evaluating the effect of exercise and pharmacotherapy on nonalcoholic fatty liver disease.

Design

A prospective follow-up study with purposive sampling was done at a liver clinic for 3 months. Baseline characteristics such as anthropometric measurements and biochemical parameters were recorde

SUBMITTER: Kandel A 

PROVIDER: S-EPMC10812096 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature